National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Labs at NIAID
 Info about NIAID Labs
  Comparative Medicine
  Cytokine Biology
  LAD
  LCID
  LCMI
   T-Cell Activation
   T-Cell Tolerance and Memory
   T-Cell Development
   Thymic Molecular Development
   T-Cell Biophysics Unit
  LHD
  LHBP
  LIG
  LI
  LIP
  LID
  LIR
  LICP
  MVDB
  LMVR
  LMI
  LMM
  LPD
  LPVD
  LVD
  LZP
  PSIIM
  Research Technologies
  Vaccine Research Center
 Find Key Lab Scientists
 Training in NIAID Labs


Laboratory of Cellular and Molecular Immunology

T-Cell Activation Section

Ronald H. Schwartz, M.D., Ph.D.

Chief, Laboratory of Cellular and Molecular Immunology
Chief, T-Cell Activation Section

Description of Research Program

Our laboratory discovered the phenomenon of T-cell anergy and has been interested over the past 15 years in understanding its molecular basis and its in vivo relevance in murine model systems. We are currently using molecular biology and protein biochemistry approaches to characterize the molecules responsible for the induction and maintenance of T-cell clonal anergy in vitro.

At the same time, we have developed an in vivo anergy model using CD4+ T cells from T-Cell Receptor (TCR) transgenic mice transferred into a second transgenic mouse expressing the antigen. The anergic state that develops, which we call adaptive tolerance, appears to involve a receptor desensitization process distinct from clonal anergy. We are actively pursuing the molecular mechanisms behind this state and the process by which it is induced. The double transgenic mice also develop a mild form of chronic arthritis, whose pathogenesis we are attempting to elucidate.

One of the major inhibitory effects in clonal anergy is the down-regulation of IL-2 gene transcription. In studying this process we serendipitously discovered that the promoter region of the IL-2 gene in naïve T cells is rapidly and selectively demethylated by an active process following TCR stimulation. This has led us into a characterization of chromatin structural changes occurring in several cytokine genes during T-cell development. In the past few years this area has become a second major focus of research in the laboratory.

Awards

Merck Award in Chemistry, Soma Weiss Award in Medical Research, U.S. Public Health Service Distinguished Service Medal.

Memberships

  • American Association of Immunologists
  • Clinical Society of Immunology

Editorial Boards

  • Immunity
  • Current Opinions in Immunology

Research Group Members

Nevil Singh, Kyungho Choi, Susan McKarns, Satoru Ishihara, Seeyoung Choi, Chuan Chen, Betsy Majane.

Selected Recent Publications

(View current list in PubMed.)

Schwartz, RH. T cell anergy. Annu Rev Immunol. 2003. 21: 305-334.

Singh NJ, Schwartz RH. The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells. J Exp Med. 2003. 198: 1107-1117.

Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nature Immunol. 2003. 4: 235-240.

Schwartz RH, Mueller DL. Immunological Tolerance. In Paul WE, ed. Fundamental Immunology. Philadelphia: Lippincott, Williams & Wilkins; 2003: 901-934.

back to top


Contact Info

Ronald H. Schwartz, M.D., Ph.D.
Phone: 301-496-1257
Fax: 301-496-0877
E-mail: rs34r@nih.gov
Mail:
Bldg. 4, Rm. 111
4 Center Drive
MSC 0420
Bethesda, MD 20892-0420


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)


NIH Logo

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

NIAID Logo

Search in Labs at NIAID
 
Print Icon Print this page
E-mail Icon E-mail this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Contact Info

Ronald H. Schwartz, M.D., Ph.D.
Phone: 301-496-1257
Fax: 301-496-0877
E-mail: rs34r@nih.gov
Mail:
Bldg. 4, Rm. 111
4 Center Drive
MSC 0420
Bethesda, MD 20892-0420


See Also

 Division of Intramural Research (DIR)

 Vaccine Research Center (VRC)